IPS Centro Cientifico-Asistencial S.A.S
Barranquilla 080020
2 studies enrolling now · 3 studies all time
What they study most
Cardiovascular Diseases, Diabetes Mellitus, Type 2, Dyslipidemia, Heart Failure, Hypertension, Type2 Diabetes
Studies at this site
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
- A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure — Recruiting now
- Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early